{"id":"https://genegraph.clinicalgenome.org/r/d35ff1da-7306-43ef-9fc4-9841e6c000d7v1.4","type":"EvidenceStrengthAssertion","dc:description":["*SMARCB1* was first reported in relation to autosomal dominant Coffin-Siris syndrome (CSS) in 2012 (PMID: 22426308). Coffin-Siris syndrome is characterized by intellectual disability, coarse facial features, hypertrichosis, sparse scalp hair, and hypoplastic or absent fifth fingernails or toenails. Five missense variants and inframe deletions, including recurrent p.(Lys364del) and p.(Arg37His), reported in 20 probands in 6 publications (PMIDs: 22426308, 23815551, 23906836, 23929686, 25168959, 29907796) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism for disease is dominant-negative (PMID: 31759698).\n\nThis gene-disease relationship is also supported by animal and cell culture models (PMIDs: 31273213, 31759698). Mice with heterozygous disruption of *Smarcb1* exhibit brain midline abnormalities like those seen in CSS individuals (PMID: 31273213). In human induced plurpotent stem cells genetically modified to harbor the recurrent inframe variant p.(Lys364del), neuron count and neurite outgrwoth are diminished, and gene expression is downregulated (PMID: 31759698).\n\nIn summary, there is definitive evidence to support the relationship between *SMARCB1* and autosomal dominant Coffin-Siris syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 15, 2023 (SOP Version 9).\n","*SMARCB1* was first reported in relation to autosomal dominant Coffin-Siris syndrome (CSS) in 2012 (PMID: 22426308). Coffin-Siris syndrome is characterized by intellectual disability, coarse facial features, hypertrichosis, sparse scalp hair, and hypoplastic or absent fifth fingernails or toenails. Five missense variants and inframe deletions, including recurrent p.(Lys364del) and p.(Arg37His), reported in 20 probands in 6 publications (PMIDs: 22426308, 23815551, 23906836, 23929686, 25168959, 29907796) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism for disease is dominant-negative (PMID: 31759698).\n\nThis gene-disease relationship is also supported by animal and cell culture models (PMIDs: 31273213, 31759698). Mice with heterozygous disruption of *Smarcb1* exhibit brain midline abnormalities like those seen in CSS individuals (PMID: 31273213). In human induced pluripotent stem cells genetically modified to harbor the recurrent inframe variant p.(Lys364del), neuron count and neurite outgrwoth are diminished, and gene expression is downregulated (PMID: 31759698).\n\nIn summary, there is definitive evidence to support the relationship between *SMARCB1* and autosomal dominant Coffin-Siris syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 15, 2023 (SOP Version 9).\n"],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d35ff1da-7306-43ef-9fc4-9841e6c000d7","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ea554e80-81d2-4100-8d0e-b762ea38fe23","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ea554e80-81d2-4100-8d0e-b762ea38fe23_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2023-08-15T16:00:00.000Z","2023-08-15T04:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ea554e80-81d2-4100-8d0e-b762ea38fe23_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-02-04T19:00:01.320Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea554e80-81d2-4100-8d0e-b762ea38fe23_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea554e80-81d2-4100-8d0e-b762ea38fe23_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e6291d0-04d6-4f11-86a9-513314dd85e1","type":"EvidenceLine","dc:description":"Upgraded because of the relevance of the observed alterations to the human disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d566e8e-d42d-4852-86cd-7988ae36bba8","type":"FunctionalAlteration","dc:description":"A human iPSC line was genetically modified to harbor heterozygous SMARCB1 variants, either the recurrent K364del inframe deletion identified in multiple patients or a frameshift variant (I349Lfs*) leading to a null allele. Assay for transposase-accessible chromatin using sequencing (ATAC-seq) demonstrated that iPSC mutants with the p.K364del variant had substantially diminished accessibility relative to wild-type. K364del mutants also had differential gene expression compared to WT with a wide range of processes affected including nervous-system processes, cardiac muscle development, kidney and mesenchyme development, endocrine system development, and cell fate commitment, in agreement with findings in CSS individuals. Differentially expressed genes included numerous genes mutated in ID. Morphologic analysis of differentiated neurons derived from K364del and indel iPSCs showed decreased neuron counts and neurite outgrowth, and both phenotypes were substantially rescued with WT SMARCB1. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31759698","rdfs:label":"iPSC lines with SMARCB1 variants"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/cbf37023-6ad7-44ed-afbe-816aa9910633","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73a0e08a-39b7-40df-87d5-a19cecfe7db8","type":"FunctionalAlteration","dc:description":"HEK293T cells with the recurrent variant p.Lys364del demonstrate reduced ATPase activity and inhibited C-terminal domain binding to nucleosome (using nucleosome-peptide photocrosslinking). \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31759698","rdfs:label":"HEK293T cells with SMARCB1 patient variant"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ea554e80-81d2-4100-8d0e-b762ea38fe23_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f493fd1f-7387-45e5-b7c9-2a398c4f1705","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d98e2bd2-0b63-424d-8a45-5359ffad315d","type":"Finding","dc:description":"Mice with heterozygous Smarcb1 disruption in the nervous system (Smarcb1+/inv NesCre+/-) were smaller and had smaller brains compared to controls. Mutant mice demonstrate brain midline abnormalities like those seen individuals with Coffin-Siris Syndrome, including agenesis of the corpus callosum and vermis hypoplasia. Smarcb1 transcript levels were significantly reduced in mutant brain tissue to about 70% of control levels. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31273213","rdfs:label":"Mouse model ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/ea554e80-81d2-4100-8d0e-b762ea38fe23_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fd950ae-0676-4aa8-bef0-a89edc681391","type":"EvidenceLine","dc:description":"0.5 points added for recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fd950ae-0676-4aa8-bef0-a89edc681391_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25168959","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.5(SMARCB1):c.1091_1093del (p.Lys364del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10575547"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/34592fb3-8e08-420a-9b8d-aa3cda9ef66f","type":"EvidenceLine","dc:description":"0.5 points added for recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34592fb3-8e08-420a-9b8d-aa3cda9ef66f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25168959","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f05112f9-64bc-4792-a137-3776cd9ad671","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f05112f9-64bc-4792-a137-3776cd9ad671_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23815551","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/21bb09ee-483f-41b6-86dc-e07c6a7a53b1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21bb09ee-483f-41b6-86dc-e07c6a7a53b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/39ae3bbc-bd12-463a-901d-b6a75757623a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.5(SMARCB1):c.1096C>T (p.Arg366Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10588715"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9969ed9d-25e3-4de1-a15c-b2425343fac7","type":"EvidenceLine","dc:description":"0.5 points added for recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9969ed9d-25e3-4de1-a15c-b2425343fac7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25168959","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3445b85c-a935-4f0e-8ce5-b46b1eabd5cd","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3445b85c-a935-4f0e-8ce5-b46b1eabd5cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23929686","allele":{"id":"https://genegraph.clinicalgenome.org/r/73125e5b-4e6c-45af-bc5d-60ca1c5242a5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.5(SMARCB1):c.1089G>T (p.Lys363Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410913795"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dcfd856e-5bf9-452a-aa4e-a5ba9ec44754","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcfd856e-5bf9-452a-aa4e-a5ba9ec44754_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23929686","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/de7bb80d-f0db-405c-bf24-54c249168e75","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de7bb80d-f0db-405c-bf24-54c249168e75_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23906836","allele":{"id":"https://genegraph.clinicalgenome.org/r/0f4a28b7-0ca7-494b-8b14-c96a4a8de10a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.5(SMARCB1):c.1121G>A (p.Arg374Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043146"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c51c7440-a593-4b0f-aac7-c0126dc8f2c5","type":"EvidenceLine","dc:description":"0.5 points added for recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c51c7440-a593-4b0f-aac7-c0126dc8f2c5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25168959","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c03bddf4-18e8-41cb-85c6-429f8aa3cfa2","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c03bddf4-18e8-41cb-85c6-429f8aa3cfa2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29907796","allele":{"id":"https://genegraph.clinicalgenome.org/r/285e465a-e4db-4e7b-ae96-70bf84d76a81","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003073.5(SMARCB1):c.110G>A (p.Arg37His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA145398"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5758e1e1-8b85-4885-8754-c9259d941f9d","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5758e1e1-8b85-4885-8754-c9259d941f9d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29907796","allele":{"id":"https://genegraph.clinicalgenome.org/r/285e465a-e4db-4e7b-ae96-70bf84d76a81"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/819fa4e1-0c8c-4589-8da1-e6c1450fc377","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/819fa4e1-0c8c-4589-8da1-e6c1450fc377_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22426308","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bd34111b-7b51-496f-8f62-1d5230f8b71c","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd34111b-7b51-496f-8f62-1d5230f8b71c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23929686","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c158be4f-6337-4b64-85d0-7b981536d26a","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c158be4f-6337-4b64-85d0-7b981536d26a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29907796","allele":{"id":"https://genegraph.clinicalgenome.org/r/285e465a-e4db-4e7b-ae96-70bf84d76a81"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9e99156e-b24a-4e81-af0b-f8a2beb2e281","type":"EvidenceLine","dc:description":"0.5 points added for recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e99156e-b24a-4e81-af0b-f8a2beb2e281_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25168959","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/99ed0123-6b6a-4495-9a96-b3ce448e7c76","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99ed0123-6b6a-4495-9a96-b3ce448e7c76_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22426308","allele":{"id":"https://genegraph.clinicalgenome.org/r/285e465a-e4db-4e7b-ae96-70bf84d76a81"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1357f2c6-8a1b-4a9d-bfc1-fd3287de045e","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1357f2c6-8a1b-4a9d-bfc1-fd3287de045e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29907796","allele":{"id":"https://genegraph.clinicalgenome.org/r/285e465a-e4db-4e7b-ae96-70bf84d76a81"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/68572a06-8b15-48cf-af15-e9228197ee33","type":"EvidenceLine","dc:description":"0.5 points added for recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68572a06-8b15-48cf-af15-e9228197ee33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25168959","allele":{"id":"https://genegraph.clinicalgenome.org/r/73125e5b-4e6c-45af-bc5d-60ca1c5242a5"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9b044d18-9dfd-49a1-ba16-360f6a356b7f","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b044d18-9dfd-49a1-ba16-360f6a356b7f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22426308","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6b47244a-8342-4b81-8361-ac5f15a5ca54","type":"EvidenceLine","dc:description":"0.5 points added for recurrent de novo variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b47244a-8342-4b81-8361-ac5f15a5ca54_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22426308","allele":{"id":"https://genegraph.clinicalgenome.org/r/f624933b-02c8-4e1c-b9ae-164b2d1fa0a2"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9907,"specifiedBy":"GeneValidityCriteria9","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/oikZIjZfSVc","type":"GeneValidityProposition","disease":"obo:MONDO_0015452","gene":"hgnc:11103","modeOfInheritance":"obo:HP_0000006"},"version":"1.4","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ea554e80-81d2-4100-8d0e-b762ea38fe23-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}